Cardiovascular findings and effects of enzyme replacement therapy in patients with mucopolysaccharidosis type VI
Objective: The mucopolysaccharidoses (MPS) are an important group of lysosomal storage diseases. Commonly reported cardiac involvement includes mitral leaflet thickening and accompanying prolapsus, regurgitation, and rarely, stenosis. The aim of this study was to evaluate cardiac involvement in pati...
Main Authors: | Emine Azak, Mehmet Gündüz |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-10-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-44502 |
Similar Items
-
Pregnancy in patients with mucopolysaccharidosis: a case series
by: Fiona J. Stewart, et al.
Published: (2016-09-01) -
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
by: Rossella Parini, et al.
Published: (2020-04-01) -
Features and behavior of valvular abnormalities in adolescent and adult patients in mucopolysaccharidosis: an echocardiographic study
by: Domenico Galzerano, et al.
Published: (2021-08-01) -
Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
by: Hsiang-Yu Lin, et al.
Published: (2018-08-01) -
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzyme Replacement Therapy
by: Fabiano de Oliveira Poswar, et al.
Published: (2022-01-01)